Suppr超能文献

估算骨质疏松症的患病率:工业化国家的实例。

Estimating prevalence of osteoporosis: examples from industrialized countries.

机构信息

Wade Outcomes Research and Consulting, 358 South 700 East, Suite B-432, Salt Lake City, UT, 84102, USA,

出版信息

Arch Osteoporos. 2014;9:182. doi: 10.1007/s11657-014-0182-3. Epub 2014 May 16.

Abstract

UNLABELLED

In nine industrialized countries in North America, Europe, Japan, and Australia, country-specific osteoporosis prevalence (estimated from published data) at the total hip or hip/spine ranged from 9 to 38 % for women and 1 to 8 % for men. In these countries, osteoporosis affects up to 49 million individuals.

PURPOSE

Standardized country-specific prevalence estimates are scarce, limiting our ability to anticipate the potential global impact of osteoporosis. This study estimated the prevalence of osteoporosis in several industrialized countries (USA, Canada, five European countries, Australia, and Japan) using the World Health Organization (WHO) bone mineral density (BMD)-based definition of osteoporosis: BMD T-score assessed by dual-energy x-ray absorptiometry ≤-2.5.

METHODS

Osteoporosis prevalence was estimated for males and females aged 50 years and above using total hip BMD and then either total hip or spine BMD. We compiled published location-specific data, using the National Health and Nutrition Examination Survey (NHANES) III age and BMD reference groups, and adjusted for differences in disease definitions across sources. Relevant NHANES III ratios (e.g., male to female osteoporosis at the total hip) were applied where data were missing for countries outside the USA. Data were extrapolated from geographically similar countries as needed. Population counts for 2010 were used to estimate the number of individuals with osteoporosis in each country.

RESULTS

For females, osteoporosis prevalence ranged from 9 % (UK) to 15 % (France and Germany) based on total hip BMD and from 16 % (USA) to 38 % (Japan) when spine BMD data were included. For males, prevalence ranged from 1 % (UK) to 4 % (Japan) based on total hip BMD and from 3 % (Canada) to 8 % (France, Germany, Italy, and Spain) when spine BMD data were included.

CONCLUSIONS

Up to 49 million individuals met the WHO osteoporosis criteria in a number of industrialized countries in North America, Europe, Japan, and Australia.

摘要

未加标签

在北美洲、欧洲、日本和澳大利亚的 9 个工业化国家中,从已发表的数据估计,全髋或髋/脊柱的特定国家骨质疏松症患病率(估计值)在女性中为 9%至 38%,在男性中为 1%至 8%。在这些国家中,多达 4900 万人患有骨质疏松症。

目的

标准化的特定国家患病率估计值稀缺,限制了我们预测骨质疏松症潜在全球影响的能力。本研究使用世界卫生组织(WHO)基于骨密度(BMD)的骨质疏松症定义,通过双能 X 射线吸收法(DXA)评估的 T 评分≤-2.5,估计了几个工业化国家(美国、加拿大、5 个欧洲国家、澳大利亚和日本)的骨质疏松症患病率:全髋 BMD 评估的男性和女性 50 岁及以上的骨质疏松症患病率,然后是全髋或脊柱 BMD。我们使用国家健康和营养检查调查(NHANES)III 年龄和 BMD 参考组汇编了已发表的特定位置数据,并根据来源之间疾病定义的差异进行了调整。对于美国以外的国家缺少的数据,应用了相关的 NHANES III 比值(例如,全髋处的男性与女性骨质疏松症)。必要时,从地理相似的国家推断数据。2010 年的人口计数用于估计每个国家患有骨质疏松症的人数。

结果

对于女性,根据全髋 BMD,骨质疏松症患病率从 9%(英国)到 15%(法国和德国)不等,而当包括脊柱 BMD 数据时,患病率从 16%(美国)到 38%(日本)不等。对于男性,根据全髋 BMD,骨质疏松症患病率从 1%(英国)到 4%(日本)不等,而当包括脊柱 BMD 数据时,患病率从 3%(加拿大)到 8%(法国、德国、意大利和西班牙)不等。

结论

在北美洲、欧洲、日本和澳大利亚的一些工业化国家中,多达 4900 万人符合 WHO 骨质疏松症标准。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验